ANUH PHARMA LIMITED vs CIPLA LTD
A side-by-side comparison of ANUH PHARMA LIMITED (ANUHPHR) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
ANUH PHARMA LIMITED vs CIPLA LTD are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation31
- Profitability22
- Growth11
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
ANUHPHR takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
EvenThree-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
CIPLA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has reduced debt.", "Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 24.4%"]
- − ["Company has a low return on equity of 13.8% over last 3 years."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
- − ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.